Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 26 August 2017
Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting Afte
For men with low-risk localised prostate cancer, most long-term psychological and quality-of-life outcomes were similar between men undergoing active surveillance and/or watchful waiting compared with various active treatment groups.
Published date 22 August 2017
Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite im
People with metastatic renal cell carcinoma who are elderly, female, have treatment in a non-teaching facility or have no private insurance have a reduced likelihood of receiving a cytoreductive nephrectomy even though it is strongly associated with improved survival.
Published date 19 August 2017
Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the ef
The incidence of all stages of breast cancer has increased over the past 40 years, with the greatest rise seen during the established screening period for women aged 50-69 years.
Published date 16 August 2017
All-cause survival following hepatitis B virus-hepatocellular carcinoma (HBV-HCC) has improved considerably, suggesting an impact of more effective antiviral therapy and earlier HCC diagnosis; in contrast, all-cause survival for hepatitis C virus-HCC is unchanged.
Published date 26 July 2017
Clinical consultations and investigations before and after discontinuation of endocrine therapy in w
Most women with breast cancer who discontinued endocrine therapy appeared to do so without consultation with doctors or investigations for recurrence or metastasis.
Published date 26 July 2017
Absence of back nevi, presence of many freckles, a sun-sensitive phenotypic index, and prior amelanotic melanoma increase odds for development of amelanotic melanoma.
Published date 21 July 2017
During the study period which examined incidence of vulvar cancer across 13 countries, the 5-yearly average percent change increased by 4.6% in women of all ages, 11.6% in those <60 years, while no change was observed in women ≥60 years.
Published date 27 June 2017
Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer re
Using multiple imputation to deal with "unknown" stage data recorded in the NSW Cancer Registry appears to provide valid estimates of cancer stage.
Published date 21 June 2017
The results of this study suggest differences in end-of-life care pathways dependent on patient factors, with younger, community-dwelling patients and those with a history of cancer incurring significantly greater costs.
Published date 14 June 2017
The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort conso
By using a novel population attributable fraction method, the authors estimate that there will be 74 000 avoidable body fatness-related cancers, and 40 000 avoidable tobacco and alcohol-related cancers in Australia over the next 10 years (2017-2026).
